Need for

In the onabotulinumtoxinA group, 8% required intermittent self-catheterization at 1 month, 4% at 3 months, and 2% at 6 months, with a median catheterization duration of 37 days (range, 2-203).

Effect: adverse; 8% at 1 month, 4% at 3 months, 2% at 6 months

In the onabotulinumtoxinA group, 8% required intermittent self-catheterization at 1 month, 4% at 3 months, and 2% at 6 months, with a median catheterization duration of 37 days (range, 2-203).

Effect: adverse; 8% at 1 month, 4% at 3 months, 2% at 6 months

In the onabotulinumtoxinA group, 8% required intermittent self-catheterization at 1 month, 4% at 3 months, and 2% at 6 months, with a median catheterization duration of 37 days (range, 2-203).

Effect: adverse; 8% at 1 month, 4% at 3 months, 2% at 6 months

In the onabotulinumtoxinA group, 8% required intermittent self-catheterization at 1 month, 4% at 3 months, and 2% at 6 months, with a median catheterization duration of 37 days (range, 2-203).

Effect: adverse; 8% at 1 month, 4% at 3 months, 2% at 6 months

In the onabotulinumtoxinA group, 8% required intermittent self-catheterization at 1 month, 4% at 3 months, and 2% at 6 months, with a median catheterization duration of 37 days (range, 2-203).

Effect: adverse; 8% at 1 month, 4% at 3 months, 2% at 6 months

In the onabotulinumtoxinA group, 8% required intermittent self-catheterization at 1 month, 4% at 3 months, and 2% at 6 months, with a median catheterization duration of 37 days (range, 2-203).

Effect: adverse; 8% at 1 month, 4% at 3 months, 2% at 6 months

In the onabotulinumtoxinA group, 8% required intermittent self-catheterization at 1 month, 4% at 3 months, and 2% at 6 months, with a median catheterization duration of 37 days (range, 2-203).

Effect: adverse; 8% at 1 month, 4% at 3 months, 2% at 6 months

In the onabotulinumtoxinA group, 8% required intermittent self-catheterization at 1 month, 4% at 3 months, and 2% at 6 months, with a median catheterization duration of 37 days (range, 2-203).

Effect: adverse; 8% at 1 month, 4% at 3 months, 2% at 6 months

In the onabotulinumtoxinA group, 8% required intermittent self-catheterization at 1 month, 4% at 3 months, and 2% at 6 months, with a median catheterization duration of 37 days (range, 2-203).

Effect: adverse; 8% at 1 month, 4% at 3 months, 2% at 6 months

In the onabotulinumtoxinA group, 8% required intermittent self-catheterization at 1 month, 4% at 3 months, and 2% at 6 months, with a median catheterization duration of 37 days (range, 2-203).

Effect: adverse; 8% at 1 month, 4% at 3 months, 2% at 6 months

In the onabotulinumtoxinA group, 8% required intermittent self-catheterization at 1 month, 4% at 3 months, and 2% at 6 months, with a median catheterization duration of 37 days (range, 2-203).

Effect: adverse; 8% at 1 month, 4% at 3 months, 2% at 6 months

In the onabotulinumtoxinA group, 8% required intermittent self-catheterization at 1 month, 4% at 3 months, and 2% at 6 months, with a median catheterization duration of 37 days (range, 2-203).

Effect: adverse; 8% at 1 month, 4% at 3 months, 2% at 6 months

In the onabotulinumtoxinA group, 8% required intermittent self-catheterization at 1 month, 4% at 3 months, and 2% at 6 months, with a median catheterization duration of 37 days (range, 2-203).

Effect: adverse; 8% at 1 month, 4% at 3 months, 2% at 6 months

In the onabotulinumtoxinA group, 8% required intermittent self-catheterization at 1 month, 4% at 3 months, and 2% at 6 months, with a median catheterization duration of 37 days (range, 2-203).

Effect: adverse; 8% at 1 month, 4% at 3 months, 2% at 6 months

In the onabotulinumtoxinA group, 8% required intermittent self-catheterization at 1 month, 4% at 3 months, and 2% at 6 months, with a median catheterization duration of 37 days (range, 2-203).

Effect: adverse; 8% at 1 month, 4% at 3 months, 2% at 6 months

In the onabotulinumtoxinA group, 8% required intermittent self-catheterization at 1 month, 4% at 3 months, and 2% at 6 months, with a median catheterization duration of 37 days (range, 2-203).

Effect: adverse; 8% at 1 month, 4% at 3 months, 2% at 6 months

In the onabotulinumtoxinA group, 8% required intermittent self-catheterization at 1 month, 4% at 3 months, and 2% at 6 months, with a median catheterization duration of 37 days (range, 2-203).

Effect: adverse; 8% at 1 month, 4% at 3 months, 2% at 6 months

In the onabotulinumtoxinA group, 8% required intermittent self-catheterization at 1 month, 4% at 3 months, and 2% at 6 months, with a median catheterization duration of 37 days (range, 2-203).

Effect: adverse; 8% at 1 month, 4% at 3 months, 2% at 6 months

In the onabotulinumtoxinA group, 8% required intermittent self-catheterization at 1 month, 4% at 3 months, and 2% at 6 months, with a median catheterization duration of 37 days (range, 2-203).

Effect: adverse; 8% at 1 month, 4% at 3 months, 2% at 6 months

In the onabotulinumtoxinA group, 8% required intermittent self-catheterization at 1 month, 4% at 3 months, and 2% at 6 months, with a median catheterization duration of 37 days (range, 2-203).

Effect: adverse; 8% at 1 month, 4% at 3 months, 2% at 6 months

In the onabotulinumtoxinA group, 8% required intermittent self-catheterization at 1 month, 4% at 3 months, and 2% at 6 months, with a median catheterization duration of 37 days (range, 2-203).

Effect: adverse; 8% at 1 month, 4% at 3 months, 2% at 6 months

In the onabotulinumtoxinA group, 8% required intermittent self-catheterization at 1 month, 4% at 3 months, and 2% at 6 months, with a median catheterization duration of 37 days (range, 2-203).

Effect: adverse; 8% at 1 month, 4% at 3 months, 2% at 6 months

In the onabotulinumtoxinA group, 8% required intermittent self-catheterization at 1 month, 4% at 3 months, and 2% at 6 months, with a median catheterization duration of 37 days (range, 2-203).

Effect: adverse; 8% at 1 month, 4% at 3 months, 2% at 6 months

In the onabotulinumtoxinA group, 8% required intermittent self-catheterization at 1 month, 4% at 3 months, and 2% at 6 months, with a median catheterization duration of 37 days (range, 2-203).

Effect: adverse; 8% at 1 month, 4% at 3 months, 2% at 6 months

In the onabotulinumtoxinA group, 8% required intermittent self-catheterization at 1 month, 4% at 3 months, and 2% at 6 months, with a median catheterization duration of 37 days (range, 2-203).

Effect: adverse; 8% at 1 month, 4% at 3 months, 2% at 6 months

In the onabotulinumtoxinA group, 8% required intermittent self-catheterization at 1 month, 4% at 3 months, and 2% at 6 months, with a median catheterization duration of 37 days (range, 2-203).

Effect: adverse; 8% at 1 month, 4% at 3 months, 2% at 6 months

In the onabotulinumtoxinA group, 8% required intermittent self-catheterization at 1 month, 4% at 3 months, and 2% at 6 months, with a median catheterization duration of 37 days (range, 2-203).

Effect: adverse; 8% at 1 month, 4% at 3 months, 2% at 6 months